Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Nyxoah SA
  6. Summary
    NYXH   BE0974358906

NYXOAH SA

(NYXH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
07/20/2021 07/21/2021 07/22/2021 07/23/2021 07/26/2021 Date
28.05(c) 28(c) 27.5(c) 27.65(c) 26.95(c) Last
33 610 4 180 4 123 15 174 28 841 Volume
+2.56% -0.18% -1.79% +0.55% -2.53% Change
More quotes
Estimated financial data (e)
Sales 2021 2,20 M 2,60 M 2,60 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 7,30 M 8,62 M 8,62 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 686 M 810 M 809 M
Capi. / Sales 2021 312x
Capi. / Sales 2022 93,9x
Nbr of Employees 79
Free-Float 34,3%
More Financials
Company
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient... 
More about the company
All news about NYXOAH SA
07/14NYXOAH : Publication relating to a transparency notification
AQ
07/09NYXOAH : Raises $98 Million In Nasdaq IPO
MT
07/08NYXOAH : Announces Closing of Nasdaq Initial Public Offering and Underwriters' F..
AQ
07/06NYXOAH S.A.(NASDAQGM : NYXH) added to NASDAQ Composite Index
CI
07/02SECTOR UPDATE : Health Care Stocks Posting Gains Ahead of Friday Close
MT
07/02NYXH : Belgium's Nyxoah Shares Rise in Stock Market Debut
MT
07/02NYXH : Nyxoah Prices US IPO at $30 Per Share
MT
06/25NYXOAH : Launches Public Offering Of Ordinary Shares In US
MT
06/25Nyxoah to Launch Registered Public Offering of 2.8 Million Ordinary Shares in..
MT
06/25Nyxoah Announces Launch of Proposed Public Offering in the United States
GL
06/11Belgium's Nyxoah Files For IPO on NASDAQ Global Market in US
MT
06/10Nyxoah S.A. Announces Consolidated Earnings Results for the First Quarter End..
CI
06/10NYXOAH SA : 1st quarter results
CO
06/10NYXOAH SA : Public takeover bid
CO
06/07NYXOAH : Sleep Device Meets Primary Endpoint of Clinical Study
MT
More news
News in other languages on NYXOAH SA
07/26Brussel opent lager
07/23Brussel opent hoger
07/22Brussel opent alweer hoger
07/21Optimistische beurs tijdens Nationale Feestdag
07/19Bel20 samen met Europese beurzen kopje onder
More news
Chart NYXOAH SA
Duration : Period :
Nyxoah SA Technical Analysis Chart | NYXH | BE0974358906 | MarketScreener
Technical analysis trends NYXOAH SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 26,95 €
Average target price 27,00 €
Spread / Average Target 0,19%
Managers and Directors
Olivier Taelman Chief Executive Officer & Executive Director
Fabian Suarez Gonzalez Chief Financial Officer
Robert Taub Chairman
Guillaume Raux Vice President-Clinical & Regulatory Affairs
Roi Tsukran Director-Engineering, Research & Development
Sector and Competitors